Impax Asset Management Group »

Regeneron Pharmaceuticals shares owned by Impax Asset Management Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Impax Asset Management Group from 13F filings

Historical chart of Impax Asset Management Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Impax Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Impax Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.9M 5.6k 1051.24
2024-06-30 $5.7M 5.4k 1051.03

More positions owned by Impax Asset Management Group

Microsoft Corp Common Stock (MSFT)
Linde Common Stock (LIN)
American Water Works Common Stock (AWK)
Pentair Common Stock (PNR)
NVIDIA Corp Common Stock (NVDA)
TE Connectivity Common Stock
Applied Materials Common Stock (AMAT)
Hubbell Common Stock (HUBB)
Mastercard Common Stock (MA)
Cintas Corp Common Stock (CTAS)
RenaissanceRe Holdings Common Stock (RNR)
Boston Scientific Corp Common Stock (BSX)
Veralto Corp Common Stock (VLTO)
Thermo Fisher Scientific Common Stock (TMO)
Aptiv Common Stock (APTV)

View all positions for Impax Asset Management Group

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals